antitoxin modules," which consist of a pair of genes encoding two components, one for a stable toxin and the other for an unstable antitoxin (Gerdes et al. 2005) . The antitoxin and toxin are coexpressed, and their expression and function are negatively autoregulated either by the complex of antitoxin and toxin or by antitoxin alone. When the coexpression of antitoxin and toxin is inhibited, the antitoxin is rapidly degraded by a specific protease, enabling the toxin to act on its target. Such a genetic system for bacterial cell growth inhibition has been reported in a number of E. coli extrachromosomal elements (Gerdes et al. 2005) .
One of the addiction modules on the E. coli chromosome, the mazEF system, consists of two adjacent genes, mazE and mazF, located downstream from the relA gene (Aizenman et al. 1996) . MazF is a stable toxin, whereas MazE is a labile antitoxin that is quickly degraded by ChpPA, an ATP-dependent serine protease (Aizenman et al. 1996) . It has been recently demonstrated that MazF is a sequence-specific endoribonuclease that specifically cleaves E. coli mRNA at the ACA triplet sequence to block de novo protein synthesis, resulting in cell growth arrest and subsequent bacterial cell death (Zhang et al. 2003) . Furthermore, it has been shown that MazE is responsible for antagonizing the endoribonuclease activity of MazF (Zhang et al. 2003) . The purpose of this addiction module is to provide a competitive growth advantage to the bacteria that encode it. For example, although the mazEF action causes individual cells to die, upon phage infection this gives benefit to the bacterial population by enabling phage exclusion (Hazan and Engelberg-Kulka 2004) .
As in bacteria, inhibition of protein synthesis in mammalian cells induced by ribonuclease RNA cleavage, translation silencing with antibiotics, or pathogen infection leads to programmed cell death. In response to viral infection, interferons activate RNaseL that cleaves 18S and 28S ribosomal RNA, which inhibits protein synthesis, eventually inducing apoptosis mediated by cytochrome c release and caspase-3 activation to eliminate virus-infected cells (Silverman 2003) . Virus-produced double-stranded RNA (dsRNA) activates RNA-activated protein kinase (PKR), which phosphorylates eukaryotic initiation factor 2 (eIF-2) thereby inhibiting mRNA translation, leading to apoptosis (Gil and Esteban 2000) . In turn, viruses have evolved mechanisms to evade these and other host defenses by enabling viral but not host protein synthesis (Barzilai et al. 2005) and by inhibiting apoptosis (Roulston et al. 1999; White 2006) . Adenovirus, for example, encodes gene products that block interferon-mediated gene expression, inhibit PKR activation, and prevent apoptosis (Roulston et al. 1999; . This allows viral but not cellular protein synthesis without cell death. Finally, antibiotics such as cycloheximide (CHX), puromycin, and emetin are part of the bacterial arsenal to inhibit and kill pathogens by targeting protein synthesis by various mechanisms (Meijerman et al. 1999) . Although inhibition of protein synthesis by various means is a common weapon to gain a selective advantage and is known to activate the apoptotic response in mammalian cells, the pathway utilized to activate apoptosis is not known.
In this study, we demonstrated that the bacterial toxin MazF, as in bacteria, induces striking degradation of cellular mRNA and inhibition of protein synthesis upstream of apoptosis induction in mammalian cells. MazF expression in mammalian cells causes caspase-3 activation and poly (ADP-ribose) polymerase (PARP) cleavage, which are hallmarks of apoptotic cell death, all of which were blocked by the antitoxin MazE. Interestingly, expression of MazF in immortalized baby mouse kidney (iBMK) cells deficient for bax and/or bak, or BH3-only proapoptotic genes (puma, bim, noxa, and nbk/bik) revealed that NBK/BIK and BAK were required for apoptosis induced by MazF. In addition, NBK/BIK bound to MCL-1 and BCL-X L , thereby promoting the release of BAK from the MCL-1 and BCL-X L inhibitory complexes in response to MazF induction. Moreover, BAX and BAK, BAK, or NBK/BIK-deficiency conferred resistance to cell death induced by pharmacologic inhibition of protein synthesis and by shutoff of protein synthesis induced by viral infection. As the shutoff of protein synthesis is often a cellular response to pathogens, this identifies NBK/ BIK as an MCL-1 and BCL-X L antagonist that functions in a BAK-specific apoptotic pathway to control this process.
Results

MazF induces degradation of cellular mRNA in mammalian cells
In E. coli, MazF functions as an mRNA interferase to cleave cellular mRNA, while the antitoxin MazE antagonizes the endoribonuclease activity of MazF (Zhang et al. 2003) . These findings led us to explore whether MazF functions as endoribonuclease in mammalian cells. To this end, a tetracycline (Tet)-inducible MazF expression system in T-Rex-293 cells stably expressing the Tet repressor was developed through stable cotransfection of the Tet-inducible MazF expression plasmid with pcDNA3 or the constitutive MazE expression plasmid. RT-PCR with specific primers for the MazF-or MazEcoding region demonstrated Tet-dependent expression of MazF mRNA and constitutive expression of MazE in established T-Rex-293 cell lines (data not shown). Using this system, we first examined whether cellular mRNAs were degraded in mammalian cells upon induction of MazF expression.
To assess cellular mRNA levels, total RNA was isolated from whole cells of Tet-treated or -untreated TRex-293 cells and subjected to Northern blot analysis using human GAPDH and ␤-actin cDNA probes. GAPDH and ␤-actin mRNAs were chosen as targets of MazF since GAPDH and ␤-actin genes are known to be housekeeping genes, both mRNAs exist abundantly, and both are stable under diverse conditions. In addition, GAPDH and ␤-actin mRNAs have 20 and 22 ACA sequences in their respective protein-coding regions, which are targets for MazF cleavage (Zhang et al. 2003) .
Data revealed that levels of both mRNAs were dramatically decreased in T-Rex-293 (mazF/pcDNA3) cells after 24 h, and were almost completely lost by 48 h postinduction of MazF (Fig. 1A) . In contrast, levels of both mRNAs were maintained by coexpression of MazE with MazF throughout the time course of induction, similarly to the Tet-untreated control (Fig. 1A) . The same results were obtained by real-time RT-PCR analysis using specific primers to amplify sequences of human GAPDH or ␤-actin cDNAs, each containing two ACA sequences (Fig. 1B) . The data revealed a striking decrease (>90%) of both mRNAs upon MazF induction for 72 h, whereas constant levels of both mRNAs were maintained in cells expressing both MazE and MazF, similarly to the Tetuntreated control. Furthermore, it was notable that levels of 28S and 18S ribosomal RNA did not change even when MazF was expressed for 72 h (Fig. 1A) , indicating that ribosomal RNA interacting with ribosomal proteins in cells may be protected from degradation by MazF. Taken together, the data indicate that MazF specifically eliminates ACA sequence-containing cellular mRNA but not ribosomal RNA, and that MazE neutralizes the MazF endoribonuclease function in mammalian cells, as was found for E. coli cells (Zhang et al. 2003) .
MazF inhibits protein synthesis in mammalian cells
In E. coli cells, MazF induction causes protein synthesis to be inhibited through degradation of cellular mRNA, indicating that MazF is a general inhibitor for protein synthesis (Zhang et al. 2003) . Thus, we investigated the effect of MazF on protein synthesis in T-Rex 293 cells. SDS-PAGE analysis of whole cellular protein from Tettreated T-Rex-293 (mazF/pcDNA3) and T-Rex-293 (mazF/mazE) cells evaluated for 35 S-methionine incorporation at 0, 24, and 48 h post-induction of MazF demonstrated that protein synthesis was strikingly inhibited as rapidly as 24 h (Fig. 1C) , clearly indicating that all mRNAs with ACA sequences were degraded by MazF. In contrast, coexpression of MazE clearly prevented the inhibitory effect of MazF on protein synthesis (Fig. 1C,D) . Furthermore, the loss of 35 S-methionine incorporation was not due to an overall loss of cellular protein in MazF-expressing cells, as total protein levels remained constant over the 48-h induction period (Fig.  1C) . The data indicate that MazF functions as an inhibitor of protein synthesis that is repressed by MazE in mammalian cells, as was found in E. coli cells (Zhang et al. 2003) .
MazF induces apoptotic cell death in mammalian cells
In E. coli, sequence-specific mRNA interference by MazF leads to rapid cell growth arrest and eventual cell death (Zhang et al. 2003) . Thus, we examined the impact of MazF expression, mRNA elimination, and inhibition of protein synthesis on mammalian cell proliferation and viability. Induction of MazF in T-Rex-293 abruptly halted cell accumulation and induced progressive cytopathic effect (CPE) during the time course of MazF induction ( Fig. 2A) . Notably, the number of attached cells was dramatically decreased at 72 h post-induction of MazF ( Fig. 2A) . In contrast, in cells where MazE was coexpressed with MazF, cell number and morphology were maintained similarly to cells without MazF induction (MazF Tet [−] and MazF/E Tet [−]) ( Fig. 2A) . Thus, MazE is capable of completely neutralizing the toxic effect of MazF on mammalian cells.
The viability of T-Rex-293 cells that express MazF was also quantified by trypan blue exclusion. When MazF expression was induced, the cell viability of T-Rex-293 (mazF/pcDNA3) cells dropped strikingly (Fig. 2B) . In contrast, coexpression of MazE with MazF conferred re- sistance to MazF-mediated killing (Fig. 2B) , and cells without MazF or MazE alone also remained viable (Fig.  2B) . Viability was also analyzed by fluorescence-activated cytometry for DNA content, and these results showed the same trends as trypan blue exclusion with apoptotic cell death by MazF induction, indicated by accumulation of a sub-G1 peak. The sub-G1 peak in T-Rex-293 (mazF/pcDNA3) increased in a time-dependent manner following Tet treatment, up to 65.9% at 72 h of induction, whereas the sub-G1 peak in T-Rex-293 (mazF/mazE) cells remained low (11.4% at 72 h of induction) (Fig. 2C ). These data demonstrate that the MazF toxin induces cell death and that the MazE antitoxin prevents MazF-dependent cell death in mammalian cells.
MazF-induced time-dependent induction of cell death was consistent with the occurrence of MazF-induced apoptosis in human 293 cells. To confirm that cell death induced by MazF was apoptosis, we examined whether caspase-3, one of the executioner caspases in the apoptosis pathway, was activated in T-Rex-293 cells expressing MazF. Western blot analysis using an antibody that recognizes cleaved and activated caspase-3 revealed the presence of the processed active form of caspase-3 in extracts from T-Rex-293 (mazF/pcDNA3) cells treated with Tet (Fig. 2D ). Active caspase-3 was also detected in extracts from T-Rex-293 (mazF/mazE) cells treated with staurosporine, a known inducer of apoptosis (Fig. 2D ). In contrast, activation of caspase-3 was inhibited by coexpression of MazE with MazF [Tet-treated T-Rex-293 (mazF/mazE) cells] (Fig. 2D ). In addition, we examined cleavage of PARP, a substrate of activated caspase-3. Cleaved PARP was detected in extracts from T-Rex-293 (mazF/pcDNA3) cells treated with Tet for 48 h, and the levels further increased at 72 h post-induction of MazF, similarly to staurosporine-treated T-Rex-293 (mazF/ mazE) cells. As expected, in extracts of cells expressing both MazE and MazF, where the processed active caspase-3 was not detected, cleaved PARP was also not present ( Fig. 2D ). Note that although 293 cells express the anti-apoptotic viral BCL-2 homolog E1B 19K that blocks apoptosis by binding to BAX and BAK , the levels are low and insufficient to block apoptosis by exogenous stimuli (also see Fig. 7 , below). Taken together, the data clearly demonstrate that MazF toxin, a sequence-specific endoribonuclease from E. coli, induces apoptotic cell death in mammalian cells, which can be prevented by MazE antitoxin coexpression. 
Levels of BCL-2 family proteins do not change during MazF-induced apoptosis
To gain insight into the mechanism of apoptosis induction by MazF upstream of caspase-3 activation, we examined anti-apoptotic (BCL-2, BCL-X L , and MCL-1) or proapoptotic (BAX, BAK, BID, BIM, NBK/BIK, and PUMA) protein levels for modulation by MazF-mediated mRNA cleavage. Cell lysates from Tet-treated T-Rex-293 (mazF/pcDNA3) and T-Rex-293 (mazF/mazE) cells for 0, 24, 48, and 72 h were subjected to Western blot analysis. The levels of BCL-2 family proteins remained unchanged, and truncated BID (tBID) was also undetectable during MazF-induced apoptosis (Fig. 3) . These data suggest that loss of anti-apoptotic BCL-2 family members BCL-2, BCL-X L , and MCL-1 or up-regulation of proapoptotic BAX, BAK, BIM, BID, NBK/BIK, and PUMA proteins were not responsible for MazF-mediated apoptosis. Finally, the absence of tBID in MazF-expressing cells suggests that the apoptotic pathway mediated by the death receptor via tBID is also not involved.
MazF-induced apoptosis requires BAK but not BAX
Proapoptotic members of the BCL-2 family, BAX and BAK, play crucial but predominantly functionally redundant roles in the mitochondria-dependent apoptosis pathway induced by numerous apoptotic stimuli downstream from BH3-only proteins (Danial and (Degenhardt et al. 2002a (Degenhardt et al. ,b, 2006 Nelson et al. 2004; Degenhardt and White 2006) . Tumor necrosis factor-␣ (TNF-␣) induces apoptosis in W2, X2, and K1 iBMK cells, whereas D3 iBMK cells are resistant to TNF-␣-induced apoptosis and that mediated by many other stimuli (Degenhardt et al. 2002b ). First, the MazF expression plasmid pcDNA4/TO/mazF was transiently cotransfected with a LacZ expression plasmid, pcDNA6/His/lacZ, into W2, D3, X2, and K1 cells for 24 and 48 h, and then a ␤-galactosidase assay was performed to monitor the impact of MazF transient expression. MazF expression for 48 h (Fig. 4A) as well as for 24 h (data not shown) in W2 cells resulted in a significant decrease of ␤-galactosidase-positive cells. In contrast, little effect on ␤-galactosidase expression was observed in D3 cells expressing MazF for 24 h (data not shown) and 48 h (Fig. 4A) . Interestingly, the number of ␤-galactosidase-positive cells in X2 cells was significantly decreased, similar to W2 cells, whereas K1 cells were preferentially resistant to MazF, suggesting that BAK deficiency was sufficient to tolerate MazF expression. Moreover, the preservation of ␤-galactosidase expression by MazF in K1 cells indicates that the loss of expression is due to apoptosis but not elimination of ␤-galactosidase mRNA.
To test if the lack of ␤-galactosidase expression in W2 and X2 cells was due to apoptosis, cells expressing MazF for 48 h were examined for active caspase-3. Immunofluoresence using anti-active caspase-3 antibody showed the presence of active caspase-3-positive cells (red in Fig.  4B ) in 58.1% of W2 cells and 47.2% of X2 cells transiently expressing MazF compared with that in <0.1% of pcDNA3-transfected W2 and X2 cells (Fig. 4B) . However, D3 and K1 cells transiently expressing MazF had few cells with activated caspase-3 (<0.1%) (Fig. 4B) , indicating that it was primarily the loss of BAK that prevented caspase-3 activation by MazF. Taken together, the data indicate that MazF induces a BAK-but not BAXdependent mechanism to activate caspase-3 and apoptosis.
To investigate whether MazE can suppress BAK-mediated apoptosis induced by MazF, MazE was transiently coexpressed for 24 and 48 h in W2, D3, X2, or K1 cells with MazF. The result from the ␤-galactosidase assay showed that MazE expression for 48 h (Fig. 4C) as well as for 24 h (data not shown) in W2 and X2 cells with MazF significantly repressed MazF-induced cell death, similarly to W2 and X2 cells with pcDNA3 or MazE expression plasmid alone. Note that in D3 cells de novo protein synthesis was almost completely blocked by stable MazF induction, whereas viability of MazF-induced D3 cells remained high, similar to that of MazF-uninduced D3 and parental D3 cells (Fig. 4D,E) . Thus, MazF expression induced the shutoff of protein synthesis and BAK-mediated apoptosis.
NBK/BIK is required for cell death induced by inhibition of protein synthesis
To identify the pathway by which inhibition of protein synthesis triggers BAK-mediated apoptosis, the functional requirement for upstream BH3-only proapoptotic proteins was examined. iBMK cell lines deficient for individual BH3-only proapoptotic proteins (PUMA, BIM, NOXA, and NBK/BIK) (Tan et al. 2005) were tested for (Fig.  5A) as well as for 24 h (data not shown) significantly decreased (Fig. 5A) , similarly to W2 and X2 cells (Fig.  4A) . Interestingly, nbk/bik −/− cells were preferentially resistant to MazF-induced cell death (Fig. 5A) , similarly to D3 and K1 cells (Fig. 4A ). This suggests that MazFmediated apoptosis requires NBK/BIK that signals through BAK.
To test if apoptosis mediated by general translation inhibition was dependent on specific BH3-only proteins, we tested the apoptotic response of puma , and noxa −/− cells treated with CHX decreased in a dose-dependent manner (Fig. 5B,C) . In contrast, when D3, K1 (Fig. 5B) , and nbk/bik −/− (Fig.  5C ) cells were treated with CHX, cell viability remained high. In addition, W2 and three independent nbk/bik −/− iBMK cell lines were clearly sensitive to TNF-␣- (Fig. 5D ) and paclitaxel-induced cell death (Fig. 5E ). In contrast, D3 cells were resistant to cell death induced by TNF-␣ and paclitaxel (Fig. 5D,E) . These results clearly indicate that NBK/BIK is the BH3-only proapoptotic protein that is required for cell death incurred by inhibition of protein synthesis in response to MazF-induced mRNA degrada- tion and CHX-induced translation inhibition upstream of BAK. Furthermore, NBK/BIK was not required for TNF-␣-mediated apoptosis (Fig. 5D ), which signals through tBID (Luo et al. 1998) , nor was NBK/BIK required for apoptosis induced by taxanes (Fig. 5E ), which is dependent on BIM (Bouillet et al. 1999; Tan et al. 2005) . These findings support the role for specific BH3-only proteins controlling the response to discrete apoptotic stimuli. (Fig. 6A) , indicating that NBK/BIK interacts with MCL-1 and BCL-X L in response to apoptosis induced by MazF. In contrast, no NBK-BIK-MCL-1 or -BCL-X L interaction is observed in MazF/MazE-expressing cells and is observed only when MazF is expressed without its inhibitor MazE (Fig. 6A) . Furthermore, immunoprecipitation with anti-MCL-1 and anti-BCL-X L antibody revealed that both endogenous MCL-1 and BCL-X L interact with endogenous BAK in cells without MazF and in those coexpressing MazE with MazF (Fig. 6B) , whereas BAK is released from complex with both MCL-1 and BCL-X L upon MazF induction and activation of the apoptotic response (Fig.  6B ). In addition, NBK/BIK interaction with both endogenous MCL-1 and BCL-X L (Fig. 6C) leads to displacement and release of BAK from these complexes in response to cell death induced by CHX in 293mazF/mazE cells (Fig.  6D) . Note that in contrast to the apoptotic pathway stimulated by DNA damage where NOXA displaces BAK from MCL-1 (Cuconati et al. 2003; Nijhawan et al. 2003; , the NBK/BIK-mediated displacement of BAK from MCL-1 does not involve degradation of MCL-1 (Fig. 3) . Thus, these data clearly indicate that NBK/BIK activates BAK by displacing it from MCL-1 or 
NBK/BIK binds MCL-1 and BCL-X L , causing the release of BAK
BCL-X L when apoptosis is induced by MazF as well as by pharmacologic means.
NBK/BIK is a mediator of apoptosis induced by adenovirus infection
Productive adenovirus infection abrogates host cell protein synthesis and triggers induction of apoptosis. To investigate whether NBK/BIK is required for adenovirusinduced apoptosis concomitant with shutoff of host cell protein synthesis, W2, bax
and nbk/bik
−/− iBMK cells were infected with wild-type adenovirus type 5 (Ad5dl309) and an E1B 19K gene deletion (anti-apoptotic vBCL-2) mutant (Ad5dl337), and monitored for CPE. Cell morphology and adherent cell number of Ad5dl309-infected W2, D3, and nbk/bik −/− cells was maintained, similar to that of mock-infected W2, D3, and nbk/bik −/− cells, indicating that E1B 19K prevents adenovirus-induced apoptosis (Fig. 7A) . Infection of W2 cells with Ad5dl337 cells resulted in almost complete destruction of the monolayer at 48 h post-infection, indicative of apoptosis leading to a decrease of adherent cell number (Fig. 7A) , as expected . In contrast, Ad5dl337-infected D3 cells were resistant to adenovirus-induced apoptosis (Fig. 7A) , as expected . Interestingly, apoptotic CPE was not observed in Ad5dl337-infected nbk/bik −/− cells, indicative of the preservation of cell viability (Fig. 7) .
Apoptosis of infected iBMK cells was assessed by monitoring activation of caspase-3. As expected, in W2 and D3 cells infected with Ad5dl309, the processed active form of caspase-3 was undetectable (Fig. 7B) . The activated caspase-3 was also not seen in nbk/bik −/− cells infected with Ad5dl309 (Fig. 7B) . Abundant levels of activated caspase-3 were present in extracts from Ad5dl337-infected W2 cells, whereas activated caspase-3 did not appear in extracts from Ad5dl337-infected D3 cells (Fig. 7B) , as expected . Interestingly, the amount of activated caspase-3 detected in nbk/bik −/− cells infected with Ad5dl337 was significantly less than that detected in Ad5dl337-infected W2 cells (Fig. 7B) , which was consistent with the resistance of nbk/bik −/− cells to Ad5dl337-induced cell death (Fig.  7A) . To ensure that iBMK cells were infected and expressing viral proteins, cell lysates were analyzed for E1A protein levels. Since E1A was used to immortalize the iBMK cells, low levels of E1A protein expression were detected in uninfected cells (Fig. 7B) . E1A levels increased significantly in Ad5dl309-infected W2, D3, and nbk/bik −/− cells (Fig. 7B) , indicating that virally in- fected cells expressed E1A from the viral genome. Higher levels of E1A were observed in Ad5dl337-infected D3 and nbk/bik −/− cells (Fig. 7B) , indicating that production of E1A in Ad5dl337-infected D3 and nbk/bik −/− cells was due to absence of apoptosis by deficiency of BAX, BAK, and NBK/BIK. Thus, data indicate that NBK/BIK is the BH3-only protein that regulates apoptosis induced by adenovirus infection upstream of BAX and BAK.
Discussion
Protein synthesis, apoptosis, and the host response to pathogens
Degradation of mRNA and consequent shutoff of protein synthesis are evolutionally conserved mechanisms in the arsenal of defense responses shared among bacteria through mammals. Bacteria, for example, use the MazF/E addiction module such that sequence-specific mRNA cleavage and degradation inhibits protein synthesis to eliminate competitive bacteria to gain a selective growth advantage (Aizenman et al. 1996; Zhang et al. 2003; Gerdes et al. 2005) . In mammals, virus infection activates the interferon response and RNaseL-mediated degradation of 28S and 18S ribosomal RNAs, which inhibits protein synthesis as part of the host antiviral response (Silverman 2003) . Furthermore, PKR activated by virus-produced dsRNA phosphorylates eIF-2␣, leading to inhibition of host protein translation, and eventually to apoptosis that eliminates virus-infected cells (Gil and Esteban 2000) . Adenovirus prevents host cell protein synthesis in large part by causing the dephosphorylation and inactivation of the translation initiation factor capbinding subunit elF-4E (Zhang et al. 1994 ). This favors translation of uncapped viral mRNA at the expense of host cellular mRNAs. This and other viral functions trigger both p53-dependent and -independent apoptosis that are inhibited by expression of a virally encoded anti-apoptotic BCL-2 homolog E1B 19K (Roulston et al. 1999; . Viruses, in turn, encode countermeasures circumventing PKR, interferons, mRNA degradation, and translation inhibition that preferentially enable the synthesis of viral proteins. In mammals, however, inhibition of host protein synthesis during infection also leads to apoptosis as the ultimate defense mechanism, and pathogens commonly encode elegant means to disable to this apoptotic response within their repertoire of countermeasures. Among the pathogen-encoded anti-apoptotic mechanisms are viral BCL-2 homologs, BH3-only protein antagonists, BAX and BAK inhibitors Goldmacher 2005) , BH3-only protein degradation mechanisms (Fischer et al. 2004; Dong et al. 2005 ), viral inhibitor of apoptosis proteins (IAPs), and caspase inhibitors (Roulston et al. 1999) . How inhibition of protein synthesis is functionally linked to apoptosis, however, has not been clear.
Role of NBK/BIK and BAK in the apoptotic response to protein synthesis inhibition
BH3-only protein's function is linked to specific stimuli and/or specific cell types, and likely represents one of the control points that provide the specificity to apoptotic signaling pathways that ultimately converge on BAX and BAK. Despite being the first BH3-only protein to be identified (Boyd et al. 1995; Han et al. 1996) , the apoptotic pathway where NBK/BIK, also known as BLK (Hedge et al. 1998) , plays a role was not known. NBK/BIK is dispensable for murine development (Coultas et al. 2004) , partly due to functional redundancy with other BH3-only proteins. Indeed, NBK/BIK or BIM is required for normal regulation of murine spermatogenesis (Coultas et al. 2005) . Alternatively, NBK/BIK function may be more significant outside the context of normal development, instead playing a role in apoptosis in pathological conditions, perhaps in concert with other BH3-only proteins. NBK/BIK expression is associated with apoptosis in response to estrogen withdrawal in human breast cancer cells (Hur et al. 2004) , and cell surface IgM ligation in human B cell lymphomas also induces NBK/BIK accumulation that is associated with apoptosis (Jiang and Clark 2001) . Ectopic NBK/BIK expression sensitizes can- cer cells to cell death by other agents (Radetzki et al. 2002; Zou et al. 2002; Lo et al. 2005) , and its loss of expression is associated with renal cell carcinoma, suggesting a possible role in the acquisition of apoptosis resistance in tumor cells (Sturm et al. 2006) . In vitro peptide binding and transient co-overexpression experiments have suggested that NBK/BIK binds to and can antagonize anti-apoptotic BCL-2, BCL-X L , and MCL-1 Certo et al. 2006 ) but does not directly interact with or regulate BAX or BAK (Letai et al. 2002) . However, the physiological context of these potential protein interactions was not known. Our observations suggest that NBK/BIK functions in response to protein synthesis inhibition to disrupt BAK-MCL-1 and BAK-BCL-X L interaction to activate BAK. It has recently become apparent that apoptosis activation requires inactivation of both the MCL-1 and BCL-X L inhibitory mechanisms. This is exemplified by the functional cooperation between NOXA, which antagonizes MCL-1, and BAD, which antagonizes BCL-X L and is required for BAK activation and apoptosis . By binding and antagonizing both MCL-1 and BCL-X L , NBK/BIK is sufficient for apoptosis induction (Fig. 7C) . In addition to NBK/BIK, there is the possibility of an additional contribution of other BH3-only proteins to apoptosis induced by the inhibition of protein synthesis.
Function of NBK/BIK in the endoplasmic reticulum
Unlike other BH3-only proteins, NBK/BIK is not localized to mitochondria, but rather is integrated exclusively in the ER membrane, yet it regulates cytochrome c release and signaling of apoptosis from mitochondria (Han et al. 1996; Germain et al. 2002) . One possibility is that the indirect regulation of mitochondrial apoptotic events arises from sequestration of anti-apoptotic BCL-2-like proteins away from mitochondria in the endoplasmic reticulum. Alternatively, NBK/BIK has been reported to regulate Ca ++ release from endoplasmic reticulum stores in a BAX-and BAK-dependent fashion, which may indirectly affect mitochondrial apoptotic function (Mathai et al. 2005) . The endoplasmic reticulum is a prominent location for cellular protein synthesis, placing NBK/BIK in an appropriate intracellular compartment for regulating the apoptotic response to the perturbation of protein synthesis.
How NBK/BIK is activated by mRNA degradation and inhibition of protein synthesis is still not known. Although NBK/BIK is regulated at the level of transcription and protein stability, no up-regulation of NBK/BIK by MazF was observed (Fig. 3) . Evidence suggests that the proapoptotic activity of NBK/BIK is stimulated by phosphorylation (Verma et al. 2001 ). However, a slower migrating band corresponding to phosphorylated NBK/ BIK was not detected during MazF-induced apoptosis (Fig. 3) , suggesting that phosphorylation of NBK/BIK may not be involved in MazF-induced apoptosis. Alternatively, inhibition of protein synthesis could cause preferential loss of an anti-apoptotic NBK/BIK antagonist, resulting in the stimulation of its apoptotic activity. However, MazF did not reduce the levels of any apoptotic regulators examined (Fig. 3) . Thus, the identity of a potential NBK/BIK-negative regulator remains to be determined.
Inhibition of NBK/BIK by viral homologs of BCL-2
Adenovirus infection induces E1A-mediated p53-dependent or -independent apoptosis (Teodoro et al. 1995; White 2006) . The p53-dependent apoptotic pathway in infected cells is caused by E1A expression and interaction with RB and p300, and activation of a DNA damage response (Chiou and White 1997; Samuelson and Lowe 1997; Cuconati et al. 2003; White 2006) . This triggers p53 accumulation and target gene expression, and BAXand BAK-mediated apoptosis (White 2006) . The E1B 55K protein binds directly to and inhibits p53, substantially mitigating both p53's growth arrest and apoptosis activity, but the E1B 19K protein is still sufficient to inhibit all of the proapoptotic activity of p53 indirectly by binding to and inhibiting BAX and BAK (White 2006) . These activities within E1B ensure inactivation of p53 function in infected cells.
The trigger for the p53-independent pathway in infected cells is likely due to both the p53-indepedent aspects of the DNA damage response and the shutoff of host cell protein synthesis. The p53-independent component of the DNA damage response causes the degradation of MCL-1 in proteasomes, resulting in the release of BAK from MCL-1, which is necessary but not sufficient for BAK activation (Cuconati et al. 2003) . Normally, apoptosis activation has no consequence to virusinfected cells as adenovirus encodes an anti-apoptotic BCL-2 homolog, E1B 19K, to inhibit apoptosis. Following the release of BAK from MCL-1, E1B 19K binds to activated BAK, and by doing so blocks BAX activation and apoptosis, although BAX can functionally substitute for the absence of BAK . The capacity for E1B 19K to bind and inhibit both BAX and BAK is important due to their functional redundancy, but also because some antiviral pathways such as those mediated by TNF-␣ result in the generation of tBID, which binds and activates both BAX and BAK (Perez and White 2000; Wei et al. 2000) . The specific targeting of activated BAX and BAK by E1B 19K may distinguish it from BCL-2 and BCL-X L , which has been reported to bind to BID and other BH3-only proteins upstream of BAX and BAK (Cheng et al. 2001) . Interestingly, E1B 19K binds and inhibits NBK/BIK but not other BH3-only proteins, but the specific pathway this was important for was not known (Boyd et al. 1995; Han et al. 1996) . The role of NBK/BIK in mediating apoptosis in response to the inhibition of protein synthesis may be the reason for E1B 19K singling out this specific BH3-only protein for inhibition. Interestingly, the viral BCL-2 homolog encoded by Epstein-Barr virus, BHRF1, also binds and inhibits NBK/BIK (Boyd et al. 1995; Elangovan and Chinnadurai 1997) .
Utility of apoptosis-resistant cells able to tolerate MazF expression and mRNA elimination
In E. coli cells, MazF induction causes the "quasi-dormancy" state, under which the cells are still fully capable of protein synthesis if all ACA sequences in the mRNA for a specific protein are altered to MazF-uncleavable sequences, allowing synthesis of a single protein in cells (Suzuki et al. 2005) . Because the single protein production (SPP) system can eliminate almost all background cellular protein synthesis (Suzuki et al. 2005) , it is anticipated that it will enable NMR structural studies on proteins in living cells under truly physiological conditions. Due to the profound defect in apoptosis in response to mRNA degradation and inhibition of protein synthesis (Fig. 4D) by MazF, nbk/bik −/− , K1, or D3 cells that are capable of maintaining viability (Fig. 4E) , this raises the possibility for SPP of ACA-less mRNAs in mammalian cells.
Materials and methods
Plasmids
The Tet-inducible MazF expression plasmid, pcDNA4/TO/ mazF, or the MazE expression plasmid, pcDNA3/mazE, was constructed by insertion of the MazF-or MazE-coding region into pcDNA4/TO or pcDNA3 (Invitrogen), respectively. The pcDNA6/His/LacZ was purchased from Invitrogen. The Myc-NBK/BIK expression plasmid pcDNA3-myc-NBK/BIK was constructed as previously described (Han et al. 1996) 
Cell lines and viral infection
Cell lines were maintained using standard tissue culture techniques with the exception that all iBMK cell lines were grown as previously described (Degenhardt et al. 2002b ). Human TRex-293 cell lines that stably express MazF alone (mazF/ pcDNA3) and that coexpress MazE with MazF (mazF/mazE), and BAX/BAK-deficient D3/mazF iBMK cells that stably express MazF alone were established through stable cotransfection with the Tet repressor expression plasmid (pcDNA6/TR) and either pcDNA4/TO/mazF and pcDNA3 or pcDNA4/TO/ mazF and pcDNA3/mazE by PolyFect Transfection Reagent (Qiagen, Inc.) according to the manufacturer's instructions, and were selected as follows: pcDNA6/TR, 5 µg/mL blasticidin; pcDNA4TO/mazF, 40 µg/mL zeocin; pcDNA3/mazE, 0.5 µg/ mL geneticin. Infection of iBMK cells with the wild-type adenovirus (Ad5dl309) or the E1B 19K gene deletion mutant (Ad5dl337) was performed as previously described .
Viability assays
The viability of T-Rex-293 cell lines was determined by trypan blue exclusion and FACS analysis as previously described (Degenhardt et al. 2002b ). ␤-Galactosidase assays to determine the viability of iBMK cells coexpressing LacZ and MazF were preformed as previously described (Han et al. 1996) . ␤-Galactosidase-positive blue cells and the total number of cells (∼200) were independently counted. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay to measure the viability of iBMK cells treated with paclitaxel, CHX, or both mouse TNF-␣ and CHX was performed as previously described (Ioffe et al. 2004) .
Western blotting, immunofluorescence, and immunoprecipitation
Western blotting, immunofluorescence, and immunoprecipitation were performed as previously described (Han et al. 1996; Perez and White 2000) with the following antibodies: anti-active caspase-3 rabbit polyclonal antibody (Cell Signaling Technology); anti-BAX rabbit polyclonal antibody, anti-BAK rabbit polyclonal antibody (NT) (Upstate Biotechnology, Inc.); anti-BID goat polyclonal antibody (R&D Systems, Inc.); anti-BIM rabbit polyclonal antibody (Alexis Biochemical); anti-BCL-2 hamster monoclonal antibody; anti-PARP monoclonal antibody (PharMingen); anti-BCL-X L mouse monoclonal antibody (Trevigen); anti-MCL-1 rabbit polyclonal antibody (Stressgen Biotechnologies); anti-PUMA rabbit polyclonal antibody ); anti-E1A monoclonal antibody; anti-actin monoclonal antibody (Oncogene Research Products); anti-Xpress monoclonal antibody, anti-Myc monoclonal antibody (Invitrogen). An antibody directed toward human NBK/BIK was generated by the expression of a GST-tagged human NBK/BIK fusion protein encoding an N-terminal 78-amino-acid region in bacteria and immunization of rabbit (Cocalico).
RNA analysis and 35
S-methionine incorporation
Northern blot analysis and real-time RT-PCR were preformed as previously described (Cuconati et al. 2003; Zhang et al. 2003) . For Northern analysis, GAPDH or ␤-actin mRNA was visualized with 32 P-labeled human GAPDH or ␤-actin cDNA. Realtime RT-PCR utilized human GAPDH primers and probe obtained from Applied Biosystems. ␤-Actin primer and probe sequences were 5Ј-GGGAAATCGTGCGTGACATT-3Ј and 5Ј-CGGATGTCCACGTCACACTT-3Ј, and 5Ј-ATCACCATTGG CAATGAGCGGTTCC-3Ј, respectively.
35
S-methionine incorporation in Tet-treated T-Rex-293 and D3/mazF cells was performed by incubation for 1 h in fresh methionine-free DMEM containing 10 µCi/mL 35 S-methionine.
